Training Example: Endo (Keenova Therapeutics and Par Health) – Review the Data, Give Your Score & Compare to the Real AI Evaluation

Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…

Endo (Keenova Therapeutics and Par Health)

(https://endo.com) 📸 Data Snapshot: May 30, 2026

Analyze the raw signals below. How would a machine score this business’s credibility?

Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.

🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Home | Introducing Keenova and Par Health (https://endo.com)
Title

Home | Introducing Keenova and Par Health

Meta

Mallinckrodt and Endo are merging to create a leading global therapeutics company with branded and generic products. Stay tuned for updates.

H1 IntroducingKeenova and Par Health
NAV_FOOTER Our Policies | Upholding Ethics and Safety | Keenova (https://endo.com/privacy-legal/)
Title

Our Policies | Upholding Ethics and Safety | Keenova

Meta

Learn more about Keenova’s Code of Conduct, global compliance program, and the policies we uphold every day to create therapies people can count on.

H1 Privacy
H2 Keenova Privacy Notice
H2 KEENOVA EEA and UK Supplemental Privacy Notice
H2 Keenova U.S. State Supplemental Privacy Notice
H2 Keenova Consumer Health Data Privacy Policy
H2 Keenova Business Contact Privacy Notice
H2 EEA and UK Business Contact Privacy Notice
H2 California Business Contact Privacy Notice
H2 Keenova Job Applicant Privacy Notice
H2 EEA and UK Job Applicant Privacy Notice
H2 California Job Applicant Privacy Notice
NAV_FOOTER Home | Introducing Keenova and Par Health (https://endo.com/responsibility/ethics-and-compliance/)
Title

Home | Introducing Keenova and Par Health

Meta

Mallinckrodt and Endo are merging to create a leading global therapeutics company with branded and generic products. Stay tuned for updates.

H1 IntroducingKeenova and Par Health
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://endo.com) Home | Introducing Keenova and Par Health
[H1] IntroducingKeenova and Par Health

On July 31, 2025, Mallinckrodt and Endo joined together to better serve patients and customers with a bold plan for the future. Following the merger, the combined company then spun off its generics and sterile injectables business as an independent company—Par Health—and rebranded the specialty therapeutics company as Keenova Therapeutics in November 2025.
Today, Keenova and Par Health operate as separate companies, each with its own mission and identity. Please select the one you would like to visit.

Keenova strives to help patients with rare, stigmatized, or unaddressed conditions live happier and healthier lives. Our areas of focus include, among others, immunology, urology, hepatology, ophthalmology, orthopedics, and critical care.

Keenova.com

Par Health is the essential pharmaceutical company. We develop high-quality generics, sterile injectables, and active pharmaceutical ingredients (APIs), supported by a robust, U.S.-advantaged manufacturing network. With over 4,000 team members worldwide, we believe great healthcare is built on getting the essentials right.

ParHealth.com
1351 chars
SUB-PAGE (https://endo.com/privacy-legal/) Our Policies | Upholding Ethics and Safety | Keenova
[H1] Privacy

[H2] Keenova Privacy Notice

Last Updated: November 3, 2025
Keenova Therapeutics plc, and their affiliates and subsidiaries (“Keenova,” “we,” “us,” “our”) understand that you (“you,” “consumers”) care about how we collect, use, and disclose information when you interact with our websites, online services, applications, and other offline business operations and services (collectively, the “Services”). We value the trust you place in us. This Privacy Notice explains how Keenova may collect, use, disclose, and protect personal information in connection with the Services.
Consumers located in the European Economic Area or the United Kingdom and residents of certain U.S. States have certain rights with respect to the collection, processing, and disclosure of their personal information. For more information, please see our EEA and UK Supplemental Privacy Notice, U.S. State Supplemental Privacy Notice, and Consumer Health Data Privacy Policy, as applicable.
Please note this Privacy Notice does not apply to personal information we collect about employees, job applicants, independent contractors, or business contacts, including health care professionals. For disclosures applicable to individuals who interact with us in those contexts, please see our Job Applicant Privacy Notice, and Business Contacts Privacy Notice.
1. PERSONAL INFORMATION WE COLLECT AND HOW WE COLLECT IT
Keenova collects personal information when you use our Services in the following ways:
When You Submit Information to Keenova: We collect personal information voluntarily provided to us, such as when a consumer contacts us via our Services, sends us an email, calls our call centers or otherwise interacts with us. We typically collect the following categories of personal information in this manner:
Identifiers such as your name, address, email address, account name, or other unique identifiers.
Personal or physical characteristics protected under federal or state law, such as gender, race, ethnicity, age, disability, AIDS/HIV status.
Commercial information, including records of personal property, products or services purchased, obtained, or considered, or other purchasing or consuming histories or tendencies.
Professional or employment-related information, including job title, employment history.
Financial and insurance information, including bank account information, enrollment in government-funded prescription benefit programs, insurance information, and redemption of co-pay assistance offers.
Audio, electronic, visual, or similar information, including voice recordings or recordings of customer service or patient support calls made to us or our call center providers.
Information in relation to questions or complaints you have submitted in relation to any of our products.
Inferences drawn from any of the information to create a profile about individuals reflecting preferences, characteristics, psychological trends, preferences, predispositions, behavior, attitudes, intelligence, abilities, and aptitudes.
Information that may be considered “sensitive” under applicable law including:
Health-related data, including information related to your medical history, conditions, and treatment, and provided in connection with reported adverse events or product complaints related to our products; and
Personal information revealing racial or ethnic origin.
If you choose not to provide personal information, we may not be able to provide the Services to you or respond to your other requests.
Through Automated Means When You Use the Services: We collect personal information passively through our services, such as via cookies, web beacons and other tracking technologies. This information may include:
Identifiers, such as IP addresses, device identifiers, and other unique identifiers.
Internet or other electronic network activity information, including, but not limited to, computer or mobile phone model, operating system version, mobile network information, browsing history, search history, and information regarding a consumer’s interaction with an internet website, application, or advertisement, including materials downloaded from our Services.
Geolocation data, such as device location.
Commercial information, including records of personal property, products or services purchased, obtained, or considered, or other purchasing or consuming histories or tendencies.
Inferences drawn from any of the information to create a profile about individuals reflecting preferences, characteristics, psychological trends, preferences, predispositions, behavior, attitudes, intelligence, abilities, and aptitudes.
From Third Parties: Keenova may collect any of the above categories of personal information from our affiliated organizations, research partners, collaborators, and service providers and non-affiliated parties who you direct or authorize to share information with us, such as your health care providers, insurance companies, or pharmacies. We also sometimes collect information from publicly accessible sources such as government records, websites, social media, and other digital platforms.
2. DATA COLLECTION TECHNOLOGY
We use data collection technology to collect information about you and your use of our Services. Data collection technology deployed through the Services may include cookies, web beacons, and similar tracking technologies:
A cookie is a small text file that is sent to or accessed from your web browser or your computer’s hard drive. A cookie typically contains the name of the domain (internet location) from which the cookie originated, the “lifetime” of the cookie (i.e., when it expires) and a randomly generated unique number or similar identifier. A cookie also may contain information about your computer, such as user settings, browsing history and activities conducted while using the Service.
A web beacon (also called a pixel tag or clear GIF) is a piece of computer code that enables us to monitor user activity and website traffic.
(To learn more about cookies and web beacons, visit www.allaboutcookies.org.)
Data collection technology helps improve functionality and determine which features users prefer by collecting information about your browser type, domain name of your Internet service provider, websites visited before and after visiting the Service, and web pages viewed. Data collection technology also allows us to compile statistics about use of the Service to help us analyze technical and navigational information about the Service, detect and prevent fraud, and deliver and target advertisements tailored to you.
Your Control of Cookies: You can review, modify, or revoke your consent to cookies by clicking on the “Cookie Settings” link that appears in the footer of each Keenova web page. Please note that your cookie settings are device, browser, and web site specific.
Do Not Track and Similar Signals: Several different technical specifications exist for transmitting user preferences concerning tracking across websites. The extent of adoption of these technical specifications varies across browsers. Our websites recognize Do Not Track (DNT) and Global Privacy Control (GPC) signals if sent by user Web browsers. Please note that these signals are device, browser, and web site specific. We do not recognize other do not track signals.
3. OUR USES OF PERSONAL INFORMATION
We may use the information we collect from or about you to:
Provide the Services, including to personalize the Services, process any transactions you request, and provide access to certain functionalities and features of Services such as account creation.
Improve the Services, including research and analytics regarding use of the Services and to ask you about your experiences with us.
Communicate with you in order to fulfill your requests, respond to your comments and inquiries, inform you about our products and services, and inform you of policy changes.
Authenticate your identity.
Deliver advertising, including interest-based advertising on our websites and on other websites and applications and providing you with other information about products and services offered by us.
Communicate with shareholders on matters relating to regulatory filings, governance guidelines, sustainability, and similar topics.
Support our clinical trials and research activities, including by providing you with information about clinical trial opportunities.
Investigate and report adverse events to regulators.
Manage our vendors, including due diligence, contract signing, compliance with regulations, screening, auditing, on-going monitoring, etc.
Enable any due diligence and other appraisals or evaluations for any actual or proposed merger, acquisition, financing transaction or joint venture contemplated by us.
Ensure network and information security, including monitoring authorized users’ access to our Services for the purpose of preventing cyber-attacks, unauthorized use of our systems and Services, prevention or detection of crime and protection of your personal information.
Defend and enforce our rights, including against legal claims that involve us.
Detect, investigate, and prevent activities that may violate our policies or be fraudulent or illegal.
Comply with our legal, regulatory, operational, and fiscal obligations.
We may combine information that you provide to us or information that we collect automatically through our Services with other information we obtain from our business records, including your use of Keenova products, services, websites and applications and, where applicable, your preferences and other personal characteristics. We also may use or combine information that we collect with information we obtain from non-affiliated parties, including demographic information and other attributes, such as census data, demonstrated interests, and organizational affiliations. Additionally, information collected from a particular browser or device may be used with another computer or device that is linked to the browser or device on which such information was collected.
We may use information we collect from or about you to create aggregated or de-identified data that does not identify you. Once the data is aggregated or de-identified, we may use it for any purpose permitted by law and we may disclose it to non-affiliated parties for their own uses. To the extent we deidentify any data originally based on personal information, we will maintain and use such data in deidentified form and will not attempt to reidentify the data.
4. OUR DISCLOSURES OF PERSONAL INFORMATION
We may disclose your information:
To our service providers who work on our behalf to help us provide and support our products and the Services. For example, we use service providers to provide us with customer relationship management services, tax and financial advice and services, auditing services, data hosting, information technology support, email hosting, marketing and analytics services, support for patient assistance programs, support in running clinical trials, and other services. We require these service providers to treat all information we provide as confidential and to use it only for providing the services for which they have been engaged.
Within the Keenova family of affiliated companies to provide you products and services as described in this Privacy Notice.
To third parties, such as media and marketing service providers, and data management and analytics service providers.
To third parties, where disclosure is necessary in connection with other business purposes including, without limitation, patient care, service quality, business management and operation, risk assessment, security, fraud and crime prevention/detection, monitoring, research and analysis, marketing, customer purchasing preferences, and trends and dispute resolution.
To a successor entity or purchaser if we are involved in a merger, sale, acquisition, divestiture, restructuring, reorganization, dissolution, bankruptcy, or other change of ownership or control by Keenova or its parent or affiliated companies (in each case, whether in whole or in part). The acquiring party or the merged entity may have different privacy practices and provide you with a new Privacy Notice.
To government, regulatory, legal authorities, outside legal counsel, and other third parties (i) as required or permitted by law, including any requirements from government agencies and taxing authorities; (ii) if we determine that disclosure of specific information is necessary to comply with the request of a law enforcement or regulatory agency or other legal process; (iii) to protect the rights, privacy, property, interests, or safety of Keenova or our affiliated companies, customers, employees, or the general public; (iv) to pursue available remedies or limit damages; (v) to enforce Keenova’s agreements with you; and (vi) to respond to an emergency.
In aggregated or de-identified form, for our business purposes or any other purposes permitted by applicable law.
Keenova does not rent, sell, or disclose, outside of a service provider relationship, text messaging opt-in lists or lists of mobile phone numbers.
Due to the global nature of our business, the personal information that we collect from you may also be transferred to, and stored at, a destination outside the jurisdiction where you are located, including the United States, for the purposes described above.
5. OUR RETENTION OF PERSONAL INFORMATION
We retain personal information for as long as necessary to fulfil the purposes for which it was collected, including for the purposes of satisfying any legal, accounting, or reporting requirements. To determine the appropriate retention period, the amount, nature, and sensitivity of the personal information are considered, together with the necessity and purposes for the processing (including whether such purposes can be achieved through other means) and the potential risk of harm from unauthorized use or disclosure of the personal information. In certain cases (e.g., in pending litigation matters or where the law requires us to) your personal information may need to be kept for longer periods of time.
6. SECURITY OF PERSONAL INFORMATION
Keenova deploys administrative, physical, and technical safeguards intended to help protect information that we collect, process, and store. Unfortunately, however, no safeguards are foolproof. Your use of our Services is at your own risk. You are responsible for maintaining the security of your account credentials and other authentication involved in obtaining access to password-protected or secure areas of our Services. We will treat access to our Services through your account credentials as authorized by you. Unauthorized access to password-protected or secure areas is prohibited and may le
15000 chars
SUB-PAGE (https://endo.com/responsibility/ethics-and-compliance/) Home | Introducing Keenova and Par Health
[H1] IntroducingKeenova and Par Health

On July 31, 2025, Mallinckrodt and Endo joined together to better serve patients and customers with a bold plan for the future. Following the merger, the combined company then spun off its generics and sterile injectables business as an independent company—Par Health—and rebranded the specialty therapeutics company as Keenova Therapeutics in November 2025.
Today, Keenova and Par Health operate as separate companies, each with its own mission and identity. Please select the one you would like to visit.

Keenova strives to help patients with rare, stigmatized, or unaddressed conditions live happier and healthier lives. Our areas of focus include, among others, immunology, urology, hepatology, ophthalmology, orthopedics, and critical care.

Keenova.com

Par Health is the essential pharmaceutical company. We develop high-quality generics, sterile injectables, and active pharmaceutical ingredients (APIs), supported by a robust, U.S.-advantaged manufacturing network. With over 4,000 team members worldwide, we believe great healthcare is built on getting the essentials right.

ParHealth.com
1351 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
28Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 0 0
/privacy-legal/ 28 0
/responsibility/ethics-and-compliance/ 0 0
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage — no schema detected (entity gap)
/privacy-legal/ — no schema detected (entity gap)
/responsibility/ethics-and-compliance/ — no schema detected (entity gap)

Your Diagnosis

Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.

Information Density 0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence 0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof 0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint 0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority 0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score 0 / 100
💡 Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)

These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.

Information Density

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Semantic Alignment

Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.

Trust & Proof

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Commodity Fingerprint

Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.

Identity & Authority

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: Endo (Keenova Therapeutics and Par Health) (endo.com)

https://endo.com 📍 Industry: Medical Devices, Pharma & Biotech
52 BS / 100

Endo.com currently functions as a ‘ghost ship’ transition portal that offers high-level corporate narrative but zero pharmaceutical substance. It serves as a navigational bridge following a merger, which explains the high BS score regarding actual proof and identity, as the substance has been migrated to child domains. The presence of ‘reviews’ on a privacy page is a definitive technical red flag for trust-theatre leakage.

Info Density Power-words vs. Substance ratio.
11
37% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
5
25% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
13
65% BS
Commodity Fingerprint Detection of industry clichés/templates.
10
67% BS
Identity & Authority Expert verifiability & Schema depth.
13
87% BS

Immediately implement Organization and Pharma-specific schema to validate corporate identity during the transition. Replace the duplicate ethics page content with specific Code of Conduct and Compliance framework details to provide substance. Remove the anomalous review counts from legal and privacy pages to eliminate trust-theatre flags. Add a summary of the clinical pipeline for Keenova and a list of FDA-approved products for Par Health to ground the marketing claims in evidence.

The site content strongly aligns with the Pharma and Biotech industry, specifically referencing therapeutic areas like immunology and urology, as well as pharmaceutical components like APIs and sterile injectables. It correctly uses industry-specific terminology regarding mergers, spinoffs, and regulatory compliance within a therapeutic context.

“The score of 52 is driven primarily by the lack of technical authority (Step 5) and the absence of verifiable proof (Step 3). While the information is coherent regarding the merger (Step 2), it fails to provide the density of data required to move from 'Marketing Signal' to 'Substance'. The presence of trust theatre flags on non-reviewable pages significantly penalized the Trust and Proof pillar.”

Verified Analysis Date: May 30, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Brand AI Reputation